Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 19/20 | 0.75 |
| ▸ | ROCK1 | Q13464 | 18/20 | 0.75 |
| ▸ | RPS6KA1 | Q15418 | 15/20 | 0.75 |
| ▸ | AKT2 | P31751 | 13/20 | 0.75 |
| ▸ | RPS6KA5 | O75582 | 10/20 | 0.75 |
| ▸ | AKT3 | Q9Y243 | 8/20 | 0.75 |
| ▸ | CIT | O14578 | 1/20 | 0.75 |
| ▸ | DCLK1 | O15075 | 1/20 | 0.75 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.75 |
| ▸ | NUAK1 | O60285 | 1/20 | 0.75 |
| ▸ | PIP5K1C | O60331 | 1/20 | 0.75 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.75 |
| ▸ | ULK1 | O75385 | 1/20 | 0.75 |
| ▸ | RPS6KA4 | O75676 | 1/20 | 0.75 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.75 |
| ▸ | SMC2 | O95347 | 1/20 | 0.75 |
| ▸ | LATS1 | O95835 | 1/20 | 0.75 |
| ▸ | PAK4 | O96013 | 1/20 | 0.75 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.75 |
| ▸ | PRKCB | P05771 | 1/20 | 0.75 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30510962 | 1.00 | AKT1 (0.75) | AKT1ROCK1RPS6KA1AKT2RPS6KA5 | |
| SCHEMBL13693040 | 0.87 | AKT1 (0.80) | AKT1ROCK1RPS6KA1AKT2RPS6KA5 | |
| SCHEMBL13461478 | 0.87 | AKT1 (0.80) | AKT1ROCK1RPS6KA1AKT2RPS6KA5 | |
| Gsk-690693 SCHEMBL2195376 | 0.85 | AKT1 (1.00) | AKT1ROCK1RPS6KA1AKT2RPS6KA5 | |
| Gsk-690693 SCHEMBL310452 | 0.85 | AKT1 (1.00) | AKT1ROCK1RPS6KA1AKT2RPS6KA5 | |
| Gsk-690693 SCHEMBL29387832 | 0.85 | AKT1 (1.00) | AKT1ROCK1RPS6KA1AKT2RPS6KA5 | |
| SCHEMBL14050839 | 0.83 | AKT1 (0.79) | AKT1ROCK1RPS6KA1AKT2RPS6KA5 | |
| SCHEMBL4071365 | 0.81 | AKT1 (0.68) | AKT1ROCK1RPS6KA1AKT2RPS6KA5 | |
| SCHEMBL3487696 | 0.81 | AKT1 (1.00) | AKT1ROCK1RPS6KA1AKT2RPS6KA5 | |
| SCHEMBL4804066 | 0.80 | AKT1 (0.54) | AKT1ROCK1RPS6KA1AKT2RPS6KA5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230167106-A1 | SERINE THREONINE KINASE (AKT) DEGRADATION / DISRUPTION COMPOUNDS AND METHODS OF USE | ICAHN SCHOOL MED MOUNT SINAI (US) | 2023-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230167106-A1 | SERINE THREONINE KINASE (AKT) DEGRADATION / DISRUPTION COMPOUNDS AND METHODS OF USE | MKNK1, MKNK2, MTOR | AKT1 12/4885ROCK1 2362/4885RPS6KA1 48/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.